Health Matters: Canada to use Pfizer's 'Abrysvo' RSV vaccine

Pfizer says Canada has selected its "Abrysvo" RSV vaccine for use in adults 60 and over for the upcoming virus season. "Abrysvo" is also approved for use in pregnant people to provide protection to infants. Katherine Ward has this story and more in Health Matters for Sept. 19, 2024.